Throughout the last 60 years, women have turned to hormone replacement therapy (HRT) to manage the symptoms of menopause. Yet, what was once touted as the elixir of youth in a tablet has been riddled with debate and concern as to the true benefits-and risks-it presents. Researchers who once believed that HRT treatment with either estrogen or an estrogen-progesterone combination in post-menopausal women would reduce the risk of cardiovascular disease have been presenting evidence against this theory in the last several years. Now, a recent study is mounting additional proof against its heart-health benefits.
To continue reading this article or issue you must be a paid subscriber.
Sign in
